Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Eben Tessari
»
Articles
»
BIIB
|
Eben Tessari
28
Followers
1
Following
You are currently following Eben Tessari
Stop Following
You are no longer following Eben Tessari
Profile
Articles (71)
Comments (17)
Biogen to Collaborate on Cancer Treatment
on Mar 25, 2009
•
BIIB
More on BIIB by Eben Tessari
Instablogs »
StockTalks »
Comments »
Articles by Ticker
ABMD
,
ACOR
,
AGN
,
ALNY
,
ALPMF.PK
,
ALTH
,
ARQL
,
AZN
,
BIIB
,
BMRN
,
BMS
,
BMY
,
CBST
,
CVTX
,
DNA
,
DVAX
,
ELN
,
ELXR
,
ENZN
,
ESALY.PK
,
EXEL
,
GENZ
,
GILD
,
GNLB
,
GSK
,
IDIX
,
IMCL
,
ISIS
,
JAZZ
,
JNJ
,
KOSN
,
LGND
,
LLY
,
MKGAY.PK
,
MRK
,
NVS
,
OMRI
,
ONXX
,
PDLI
,
PFE
,
RHHBY.PK
,
SCMP
,
SGP
,
SHPGY
,
SNY
,
SOMX
,
TEVA
,
TKPHF.PK
,
TPTX
,
TRCA
,
VNLS
,
VRTX
,
WYE
,
YMI
Latest Comments on Eben Tessari's Articles
User 400998
on
MS Drug Fampridine Sends Acorda Stock Way Up
: DOES ANYONE KNOW WHEN IT WILL BE AVAILABLE TO ALL OF US? IS IT...
more »
RamblinRose
on
Ascent Enters $200M Pact With Novartis
: well, there is more to pepducins than marketing; they do have the...
more »
Edward, Lord Clarendon
on
Pharma: Are Mega Mergers Good for Business?
: PLENTY OF MONEY TO BE MADE IN MERGERS!! It's easy. Lie,...
more »
raytayzmd
on
Pharma: Are Mega Mergers Good for Business?
: ...oh, probably great for business but when your health insurance...
more »
donzelion
on
Merck to Buy Schering-Plough in $41.1 Billion Cash and Stock Deal
: From a mergers perspective, a 44% cash, 56% stock deal seems...
more »
Moon Kil Woong
on
Merck to Buy Schering-Plough in $41.1 Billion Cash and Stock Deal
: I think this shows someone made a quick buck a week ago before the...
more »
Thefigman
on
Merck to Buy Schering-Plough in $41.1 Billion Cash and Stock Deal
: I think this transaction shows that Merck's pipeline might not be...
more »
Michael L
on
Merck to Buy Schering-Plough in $41.1 Billion Cash and Stock Deal
: It seems Merck never runs out of ways to disappoint its investors.
more »
donzelion
on
Astellas Proposes to Acquire CV Therapeutics for $1Billion
: I'm fairly ignorant about pharms (which is why I'm buying a...
more »
User 345757
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: Why would PFE wanna move into the low-margin biz of generics?
more »
Guero
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: You make a great point. Spot on. It is what it is. They are...
more »
Crocodilian
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: While outsiders often look at drug development as the raison...
more »
sorsorday
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: You can say the same thing for all business transaction. In...
more »
Guero
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: Pfizer pfires 800 R&D scientists even though they have no patent...
more »
Chris B
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: The evidence is in: around 70% of mergers actually destroy...
more »
Latest Comments on Eben Tessari's Articles
Latest Comments on Eben Tessari's Articles